EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

Mental health: awareness, access and influence in pharma

For this episode, the team is joined by Wendy Bartie, BMS, and Courtney Billington, Janssen Neuroscience, to talk all things mental health: awareness, access and influence in pharma.

Social sustainability, patient advocacy and policy campaigning

In this episode, Marc and Helena are joined by Leo Pharma’s Klaus League to discuss social sustainability, patient advocacy and policy campaigning.

RWE, the metrics of medical affairs and TikTok marketing

Marc and Helena are joined by Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology at AstraZeneca, and many more guests, talking medical affairs, RWE and TikTok marketing.

Driving access to digital, gene therapies and rare disease education

In this episode, Marc and Helena talk about digital access with Alira Health’s Aaron Grandy and about haemophilia with patient advocate Laurence Woollard.

2022 pharma predictions – where are we now?

In this episode, at the season’s half way point, Marc, Helena and Isabel look back at our 2022 predictions for pharma industry – were our guests right?

Meet GOLD's next catalyst - digital innovator, Davidek Herron

Marc presents exclusive snippets from an interview with our next catalist, Davidek Herron, Global Head of Digital, Roche.

Innovation, collaboration and creativity as a contact sport

Magnus Björsne, CEO, AstraZeneca BioVentureHub, discusses the impact of the pandemic on innovation, collaboration and creativity.

Pharma in China, untapped markets and drug development

In this episode, Marc and Helena talk China with Novartis’ Isabel Afonso and drug development with Farid Khan, CEO of PharmaKure. Listen now!